Speakeasy Cannabis Club Ltd.
Speakeasy Cannabis Club Ltd.
Your view on SPBBF
Overview
What the company does, where it operates, and who runs it.
About Speakeasy Cannabis Club Ltd.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Patrick Geen
- Headquarters
- 1520-6 Myers Creek Road West, Rock Creek, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Patrick Geen
- Headquarters
- 1520-6 Myers Creek Road West, Rock Creek, BC, CA
Speakeasy Cannabis Club Ltd. focuses on producing medical cannabis in Canada. It owns approximately 290 acres of land in Rock Creek, British Columbia. The company is headquartered in Rock Creek, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Speakeasy Cannabis Club Ltd., and the rating behind it. SPBBF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Speakeasy Cannabis Club Ltd.. Starting points for Speakeasy Cannabis Club Ltd.: EPS -$0.02, beta 0.27 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Speakeasy Cannabis Club Ltd.. Speakeasy Cannabis Club Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Speakeasy Cannabis Club Ltd.. Trailing twelve-month EPS for Speakeasy Cannabis Club Ltd. stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Speakeasy Cannabis Club Ltd.. Speakeasy Cannabis Club Ltd. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Speakeasy Cannabis Club Ltd. valued side by side against its closest peers. Speakeasy Cannabis Club Ltd. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Speakeasy Cannabis Club Ltd., and how their positions are changing. At a $1,315 market value, institutional positions materially move Speakeasy Cannabis Club Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Speakeasy Cannabis Club Ltd. executives and directors. Shares of Speakeasy Cannabis Club Ltd. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Speakeasy Cannabis Club Ltd.. Speakeasy Cannabis Club Ltd. is a $1,315 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Speakeasy Cannabis Club Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Speakeasy Cannabis Club Ltd.. Coverage tracks Speakeasy Cannabis Club Ltd. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.